Adverse events of raltegravir and dolutegravir

OBJECTIVE: To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir. DESIGN: Prospective cohort study. METHODS: All antiretroviral therapy (ART)-naïve and ART-experienced HIV-infected individuals from the Swiss HIV Cohort Study who...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:AIDS
Autors principals: Elzi, Luigia, Erb, Stefan, Furrer, Hansjakob, Cavassini, Matthias, Calmy, Alexandra, Vernazza, Pietro, Günthard, Huldrych, Bernasconi, Enos, Battegay, Manuel
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2017
Matèries:
Clinical Science: Concise Communications
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566167/
https://ncbi.nlm.nih.gov/pubmed/28692533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001590
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars